JNJ

Johnson & Johnson (JNJ)

Last Price$154.01.4%
Market Cap$392.3B
LTM P/E
25.2x
EPS growth
(12.7%)
PEGY
(2.7x)
Peter Lynch Fair Value
($58.0)
Undervalued (Peter Lynch formula)
(137.7%)
Stock quality
8/10
Great

JNJ Peter Lynch Fair Value

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

JNJ EPS growth & Dividend Yield

Crunching data... Almost there!

JNJ vs Peer Set: Peter Lynch Fair Value Comparison

Crunching data... Almost there!

Explore more intrinsic value tools hub for JNJ

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

What is Johnson & Johnson fair value by Peter Lynch formula?

As of Nov 15, 2024, Johnson & Johnson's fair value using the Peter Lynch formula is ($58.0) per share. The current price of $154.0 suggests Johnson & Johnson may be overvalued by this metric.

What is Johnson & Johnson Price to Earnings (P/E) ratio?

As of Nov 15, 2024, Johnson & Johnson's P/E ratio is 25.2x. This is calculated by dividing the current share price of $154.0 by the Earnings per Share (EPS) for the trailing twelve months, which is $6.1. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.

What is Johnson & Johnson earnings per share (EPS)?

Johnson & Johnson earnings per share (EPS) for the twelve months ending Nov 15, 2024, was $6.1, a (12.7%) growth year-over-year.